Nicholas E Powers

Years Active: 2019-2023
Publications (10 Years): 5

University of Colorado Denver

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado Denver Nov 23o 2016

United States

PRA :: Department of Medicine, Infectious Diseases Unit

Publications

Alberto Dinarello, Taylor S Mills, Isak W Tengesdal, Nicholas E Powers, Tania Azam, Charles A Dinarello
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions. Cells 12 (2) (2023)
Alberto Dinarello, Taylor S Mills, Isak W Tengesdal, Nicholas E Powers, Tania Azam, Charles A Dinarello
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions. Cells 12 (2) (2023)
Alberto Dinarello, Taylor S Mills, Isak W Tengesdal, Nicholas E Powers, Tania Azam, Charles A Dinarello
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions. Cells 12 (2) (2023)
Alberto Dinarello, Taylor S Mills, Isak W Tengesdal, Nicholas E Powers, Tania Azam, Charles A Dinarello
Dexamethasone and OLT1177 Cooperate in the Reduction of Melanoma Growth by Inhibiting STAT3 Functions. Cells 12 (2) (2023)
Nicholas E Powers, Benjamin J Swartzwelter, Carlo Marchetti, Dennis M De Graaf, Alexandra Lerchner, Martin Schlapschy, Rajiv Datar, Uli Binder, Carl K Edwards, Arne Skerra, Charles A Dinarello
PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis. The Journal of biological chemistry 295 (3) (2019)

Nicholas E Powers.css-eqlu8i{font-size:small;padding-left:4px;}